FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2138859054> ?p ?o ?g. }

• W2138859054 endingPage "987" @default.
• W2138859054 startingPage "973" @default.
• W2138859054 abstract "1. The inhibition of cytochrome P450 (CYP)-mediated substrate oxidations by alkylamine-based drugs was investigated in rat hepatic microsomes. The effects of pre-incubation of the drugs with NADPH-fortified microsomes on inhibition potency was evaluated in relation to the formation of metabolite intermediate (MI) complexes with CYP in vitro. 2. The selective serotonin-reuptake inhibitor fluoxetine (FLU) emerged as a potent and preferential inhibitor of CYP2C11 in rat liver microsomes. After FLU biotransformation in NADPH-supplemented microsomes, IC50 values of 2 and 1 microM were determined against CYP2C11-dependent testosterone 2alpha- and 16alpha-hydroxylation; in the absence of pre-incubation, the corresponding IC50 values were 47 and 39 microM. MI complexation of CYP appeared to contribute significantly to inhibition by FLU, as evidenced by the 21% decrease in apparent microsomal CYP content produced by 50 microM FLU in the presence of NADPH. 3. The secondary amines nisoxetine (NIS), and especially, desipramine (DES) and nortriptyline (NOR), also inhibited CYP2C11 and generated MI complexes with microsomal CYP. In contrast, with the exception of SKF-525-A, tertiary alkylamines (10 compounds) inhibited specific CYP activities but did not form MI complexes. Pre-incubation of these agents with NADPH-supplemented microsomes did not enhance inhibition of CYP activities, thus suggesting that formation of inhibitory metabolites was minimal for these compounds. 4. These findings implicate drug-mediated MI complexation of CYPs in the inhibition of hepatic biotransformation processes by secondary alkylamines. In contrast, tertiary amines did not generate significant quantities of CYP-MI complexes under the test conditions. Despite their diffusion from the CYP active site, inhibition produced by tertiary amines and stable metabolites of other drugs may be significant. However, such inhibition would be of shorter duration than that from MI complexation, which involves quasi-covalent binding to the haem and prevention of oxygen activation." @default.
• W2138859054 created "2016-06-24" @default.
• W2138859054 creator A5003967548 @default.
• W2138859054 creator A5049484821 @default.
• W2138859054 date "2003-10-01" @default.
• W2138859054 modified "2023-09-24" @default.
• W2138859054 title "Mechanism-based inhibition of CYP activities in rat liver by fluoxetine and structurally similar alkylamines" @default.
• W2138859054 cites W1579608901 @default.
• W2138859054 cites W1633747844 @default.
• W2138859054 cites W1951469402 @default.
• W2138859054 cites W1972666643 @default.
• W2138859054 cites W1978929645 @default.
• W2138859054 cites W1989925217 @default.
• W2138859054 cites W1992838841 @default.
• W2138859054 cites W1995986733 @default.
• W2138859054 cites W1998263681 @default.
• W2138859054 cites W2005244872 @default.
• W2138859054 cites W2005831358 @default.
• W2138859054 cites W2011759489 @default.
• W2138859054 cites W2023131108 @default.
• W2138859054 cites W2023198390 @default.
• W2138859054 cites W2024191422 @default.
• W2138859054 cites W2027313416 @default.
• W2138859054 cites W2036283577 @default.
• W2138859054 cites W204069928 @default.
• W2138859054 cites W2047300280 @default.
• W2138859054 cites W2052321118 @default.
• W2138859054 cites W2092063638 @default.
• W2138859054 cites W2095277039 @default.
• W2138859054 cites W2119580969 @default.
• W2138859054 cites W2152381833 @default.
• W2138859054 cites W51748036 @default.
• W2138859054 cites W78467993 @default.
• W2138859054 cites W994970986 @default.
• W2138859054 cites W1988569722 @default.
• W2138859054 doi "https://doi.org/10.1080/00498250310001602748" @default.
• W2138859054 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14555335" @default.
• W2138859054 hasPublicationYear "2003" @default.
• W2138859054 type Work @default.
• W2138859054 sameAs 2138859054 @default.
• W2138859054 citedByCount "23" @default.
• W2138859054 countsByYear W21388590542013 @default.
• W2138859054 countsByYear W21388590542016 @default.
• W2138859054 countsByYear W21388590542017 @default.
• W2138859054 countsByYear W21388590542019 @default.
• W2138859054 countsByYear W21388590542020 @default.
• W2138859054 countsByYear W21388590542022 @default.
• W2138859054 crossrefType "journal-article" @default.
• W2138859054 hasAuthorship W2138859054A5003967548 @default.
• W2138859054 hasAuthorship W2138859054A5049484821 @default.
• W2138859054 hasConcept C109650736 @default.
• W2138859054 hasConcept C181199279 @default.
• W2138859054 hasConcept C185592680 @default.
• W2138859054 hasConcept C202751555 @default.
• W2138859054 hasConcept C25642318 @default.
• W2138859054 hasConcept C2776524530 @default.
• W2138859054 hasConcept C2777477808 @default.
• W2138859054 hasConcept C2777752497 @default.
• W2138859054 hasConcept C2780216858 @default.
• W2138859054 hasConcept C2780779033 @default.
• W2138859054 hasConcept C2781109383 @default.
• W2138859054 hasConcept C27881333 @default.
• W2138859054 hasConcept C526171541 @default.
• W2138859054 hasConcept C55493867 @default.
• W2138859054 hasConcept C62231903 @default.
• W2138859054 hasConcept C86803240 @default.
• W2138859054 hasConcept C87644729 @default.
• W2138859054 hasConcept C98274493 @default.
• W2138859054 hasConceptScore W2138859054C109650736 @default.
• W2138859054 hasConceptScore W2138859054C181199279 @default.
• W2138859054 hasConceptScore W2138859054C185592680 @default.
• W2138859054 hasConceptScore W2138859054C202751555 @default.
• W2138859054 hasConceptScore W2138859054C25642318 @default.
• W2138859054 hasConceptScore W2138859054C2776524530 @default.
• W2138859054 hasConceptScore W2138859054C2777477808 @default.
• W2138859054 hasConceptScore W2138859054C2777752497 @default.
• W2138859054 hasConceptScore W2138859054C2780216858 @default.
• W2138859054 hasConceptScore W2138859054C2780779033 @default.
• W2138859054 hasConceptScore W2138859054C2781109383 @default.
• W2138859054 hasConceptScore W2138859054C27881333 @default.
• W2138859054 hasConceptScore W2138859054C526171541 @default.
• W2138859054 hasConceptScore W2138859054C55493867 @default.
• W2138859054 hasConceptScore W2138859054C62231903 @default.
• W2138859054 hasConceptScore W2138859054C86803240 @default.
• W2138859054 hasConceptScore W2138859054C87644729 @default.
• W2138859054 hasConceptScore W2138859054C98274493 @default.
• W2138859054 hasIssue "10" @default.
• W2138859054 hasLocation W21388590541 @default.
• W2138859054 hasLocation W21388590542 @default.
• W2138859054 hasOpenAccess W2138859054 @default.
• W2138859054 hasPrimaryLocation W21388590541 @default.
• W2138859054 hasRelatedWork W2059347789 @default.
• W2138859054 hasRelatedWork W2084454449 @default.
• W2138859054 hasRelatedWork W2090709712 @default.
• W2138859054 hasRelatedWork W2092063638 @default.
• W2138859054 hasRelatedWork W2116139281 @default.
• W2138859054 hasRelatedWork W2118545690 @default.
• W2138859054 hasRelatedWork W2138859054 @default.

• next